Sitilop is collaborating with Life Molecular Imaging on a new way of evaluating Tau depositions in Alzheimer’s disease

Alzheimer’s disease is the most common cause of dementia worldwide. It is a progressive neurodegenerative disorder for which we currently have no cure or disease modifying therapies to slow disease progression. Alzheimer’s disease is often preceded by a prodromal phase called mild cognitive impairment which is characterised by decline in cognitive performance. Neuropathological hallmarks of…